Sudeep Pharma Limited Updates CIN and Company Status Following Stock Exchange Listing

1 min read     Updated on 16 Jan 2026, 11:17 AM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Sudeep Pharma Limited has successfully updated its Corporate Identification Number (CIN) from U24231GJ1989PLC013141 to L24231GJ1989PLC013141 on the MCA website following its listing on BSE and NSE on November 28, 2025. The company's status has been changed from unlisted to listed, with the updated master data showing authorized capital of ₹15.00 crores and paid-up capital of ₹11.29 crores. The pharmaceutical company, incorporated in 1989 and based in Gujarat, maintains active compliance status under ROC Ahmedabad jurisdiction.

30088065

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma Limited has completed the formal update of its Corporate Identification Number (CIN) and company status on the Ministry of Corporate Affairs (MCA) website following its stock exchange listing. The pharmaceutical company informed the exchanges about this administrative update through a regulatory filing dated January 16, 2026.

CIN Update Details

The company's application to the Registrar of Companies, Gujarat, for updating its master data has been processed successfully. The changes reflect the company's transition from an unlisted to a listed entity following its debut on the stock exchanges.

Parameter: Previous Status Updated Status
CIN: U24231GJ1989PLC013141 L24231GJ1989PLC013141
Company Status: Unlisted Listed
Stock Exchange Status: No Yes

Company Profile and Listing Information

Sudeep Pharma Limited successfully listed on both BSE and NSE on November 28, 2025. The company, incorporated on December 21, 1989, operates in the pharmaceutical sector and is registered under the ROC Ahmedabad jurisdiction.

Corporate Details: Information
Registration Number: 013141
Date of Incorporation: December 21, 1989
Registered Address: 129/1/A, G.I.D.C. Estate Nandesari, Baroda, Gujarat
ROC Jurisdiction: ROC Ahmedabad
Company Category: Public, Non-government company

Financial and Compliance Status

The updated MCA master data reveals key financial parameters and compliance status of the company. Sudeep Pharma maintains active compliance status and operates as a public limited company.

Financial Parameters: Amount/Details
Authorized Capital: ₹15.00 crores
Paid-up Capital: ₹11.29 crores
Last AGM Date: August 28, 2025
Balance Sheet Date: March 31, 2025
Compliance Status: Active Compliant

Administrative Update Process

The CIN update process was initiated following the company's listing on the stock exchanges. Company Secretary and Compliance Officer Dimple Mehta signed the intimation letter digitally, confirming the completion of the administrative formalities. The updated master data from the MCA website has been submitted to both BSE and NSE for their records.

The change in CIN prefix from 'U' to 'L' is a standard procedure that indicates the company's listed status, providing transparency to stakeholders and regulatory authorities about the company's current market position.

Historical Stock Returns for Sudeep Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-3.01%+0.77%-15.15%-23.41%-23.41%-23.41%
Sudeep Pharma
View in Depthredirect
like18
dislike

Sudeep Pharma Submits Q2FY26 Earnings Call Audio Recording to Stock Exchanges

1 min read     Updated on 21 Dec 2025, 04:36 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Sudeep Pharma Limited has completed its Q2FY26 earnings call and submitted the audio recording to stock exchanges in compliance with SEBI regulations. The call was held on December 22, 2025, to discuss performance for the quarter and half-year ended September 30, 2025, with the recording now available on the company's website for stakeholder access.

27860755

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma Limited has completed its Q2FY26 results presentation and earnings call, subsequently submitting the audio recording to stock exchanges in compliance with regulatory requirements. The pharmaceutical company conducted its earnings discussion on December 22, 2025, as previously scheduled.

Earnings Call Completion

The company successfully held its Q2FY26 earnings call on Monday, December 22, 2025, at 11:30 a.m. to discuss operational and financial performance for the quarter and half-year ended September 30, 2025. Following the completion of the call, Sudeep Pharma has now submitted the audio recording to both NSE and BSE as required under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Call Details: Information
Date Held: December 22, 2025
Time: 11:30 a.m.
Purpose: Q2FY26 Results Discussion
Period Covered: Quarter and half-year ended September 30, 2025

Audio Recording Accessibility

The audio recording of the earnings call has been uploaded to the company's official website and is accessible to all stakeholders. The company has provided direct access to ensure transparency in investor communications.

Recording Access: Details
Website: https://www.sudeeppharma.com/
Direct Link: https://www.sudeeppharma.com/wp-content/uploads/2025/12/10038645.mp3
Format: MP3 Audio File
Transcript Status: To be submitted separately

Regulatory Compliance

Sudeep Pharma's submission dated December 22, 2025, references its earlier communications dated December 15, 2025, and December 21, 2025, regarding the earnings call intimation and investor presentation respectively. The company has maintained consistent compliance with SEBI listing regulations throughout the process.

Company Information

The pharmaceutical company operates from its registered office at 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, with its corporate office located at 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat.

Corporate Details: Information
CIN: U24231GJ1989PLC013141
NSE Symbol: SUDEEPPHRM
BSE Scrip Code: 544619
Website: www.sudeepgroup.com

The submission was authorized by Dimple Mehta, Company Secretary and Compliance Officer (M.No.: F13184), demonstrating the company's adherence to corporate governance standards and regulatory requirements.

Historical Stock Returns for Sudeep Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-3.01%+0.77%-15.15%-23.41%-23.41%-23.41%
Sudeep Pharma
View in Depthredirect
like17
dislike
More News on Sudeep Pharma
Explore Other Articles
592.90
-18.40
(-3.01%)